Editor’s Note: This article originally appeared on Alpha Health’s website.
Alpha Health, the first Unified Automation company for revenue cycle management in healthcare, released the results of a national online survey designed to assess how concerned Americans are about the cost of COVID-19 testing and treatment and if these concerns would prevent them from seeking care.
The survey results show consumer concerns related to the cost of COVID-19 testing and treatment are high. Fortunately, the survey results also indicate that these concerns would not prevent the majority of Americans from seeking care should they need it. However, one in five Americans (22 percent) indicate that cost concerns would prevent them from seeking testing and treatment for COVID-19. This could significantly hinder public health efforts to effectively address the disease.
Survey respondents were asked, “If you or someone in your family had COVID-19 symptoms, how concerned would you be about the cost of testing or treatment?” Click here to continue>>
News From Our Partners
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
